These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 6149527

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Molecular biology and molecular pathology of a newly described molecular disease--tyrosinemia II (the Richner-Hanhart syndrome).
    Goldsmith LA.
    Exp Cell Biol; 1978; 46(1-2):96-113. PubMed ID: 23331
    [Abstract] [Full Text] [Related]

  • 3. Corneal erosions in tyrosinosis.
    Zaleski WA, Hill A, Murray RG.
    Can J Ophthalmol; 1973 Oct; 8(4):556-9. PubMed ID: 4148055
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tyrosine aminotransferase deficiency in mink (Mustela vision): a model for human tyrosinemia II.
    Goldsmith LA, Thorpe JM, Marsh RF.
    Biochem Genet; 1981 Aug; 19(7-8):687-93. PubMed ID: 6117279
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Richner-Hanhart syndrome (tyrosinemia type II). Case report and literature review.
    al-Hemidan AI, al-Hazzaa SA.
    Ophthalmic Genet; 1995 Mar; 16(1):21-6. PubMed ID: 7648039
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Successful dietary control of tyrosinemia II.
    Machino H, Miki Y, Kawatsu T, Kida K, Matsuda H.
    J Am Acad Dermatol; 1983 Oct; 9(4):533-9. PubMed ID: 6195199
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Biochemical observations on so-called hereditary tyrosinemia.
    Gaull GE, Rassin DK, Solomon GE, Harris RC, Sturman JA.
    Pediatr Res; 1970 Jul; 4(4):337-44. PubMed ID: 4393588
    [No Abstract] [Full Text] [Related]

  • 13. Defect in soluble tyrosine aminotransferase in skin fibroblasts of a patient with tyrosinemia.
    deGroot GW, Dakshinamurti K, Allan L, Haworth JC.
    Pediatr Res; 1980 Jul; 14(7):896-8. PubMed ID: 6106182
    [No Abstract] [Full Text] [Related]

  • 14. Corneal tyrosine crystals in transient neonatal tyrosinemia.
    Driscoll DJ, Jabs EW, Alcorn D, Maumenee IH, Brusilow SW, Valle D.
    J Pediatr; 1988 Jul; 113(1 Pt 1):91-3. PubMed ID: 3385538
    [No Abstract] [Full Text] [Related]

  • 15. Novel and recurrent tyrosine aminotransferase gene mutations in tyrosinemia type II.
    Hühn R, Stoermer H, Klingele B, Bausch E, Fois A, Farnetani M, Di Rocco M, Boué J, Kirk JM, Coleman R, Scherer G.
    Hum Genet; 1998 Mar; 102(3):305-13. PubMed ID: 9544843
    [Abstract] [Full Text] [Related]

  • 16. Hepatic enzymes of tyrosine metabolism in tyrosinemia II.
    Goldsmith LA, Thorpe J, Roe CR.
    J Invest Dermatol; 1979 Dec; 73(6):530-2. PubMed ID: 41876
    [Abstract] [Full Text] [Related]

  • 17. [The metabolic basis of the hyperphenylalaninemias and tyrosinemia].
    Shintaku H.
    Nihon Rinsho; 1992 Jul; 50(7):1542-7. PubMed ID: 1357201
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.